At the non-Hodgkin Lymphoma Program, we have a staff of compassionate and experienced pediatric specialists that includes oncologists, radiation oncologists, radiologists, surgeons and stem cell transplant experts. Our physicians are focused on family-centered care: From your first visit, you’ll work with a team of professionals who are committed to supporting all of your family’s physical and psychosocial needs.
Amy L. Billett, MD
Billett is a pediatric oncologist and has worked at DF/CHCC for more than 20 years. She specializes in the treatment of lymphomas including Hodgkin disease, non-Hodgkin disease and Burkitt’s lymphoma. She also oversees patient safety and quality research for the Division of Hematology & Oncology. She is an associate professor of pediatrics at Harvard Medical School.
Kirsten Ecklund, MD
Ecklund has worked at Children’s since 1994. A pediatric radiology who specializes in diagnostic radiology and pediatric musculoskeletal radiology, she holds the vice chair of Diagnostic Radiology and the Chief of the Division of Diagnostic Radiology. She is also an assistant professor of radiology at Harvard Medical School.
Mark Daniel Fleming, MD, DPhil
Fleming is a hematopathologist and Children’s pathologist-in-chief. He specializes diagnosis of cancers of the blood and lymph systems. His research focuses on iron metabolism in the blood. He’s also an Associate Professor of Pathology at Harvard Medical School.
Frederick D. Grant, MD
Grant is a radiologist specializing in nuclear medicine and molecule imaging. His research focuses on applications of nuclear medicine to pediatric oncology. He is also an instructor in radiology at Harvard Medical School.
Karen J. Marcus, MD
Marcus joined DF/CHCC in 1989 and specializes in pediatric oncology and radiation oncology. She treats children with a wide variety of cancers including brain tumors, sarcomas, neuroblastoma, leukemias, kidney tumors and Hodgkin lymphoma. She’s an associate professor at Harvard Medical School and co-chair of Pediatric Oncology Institutional Review Board.
Robert C. Shamberger, MD
Shamberger is Children’s Chief of Surgery and has expertise in surgical oncology. He is a professor of Surgery at Harvard Medical School. His research focuses on the treatment of neuroblastoma, Ewing’s sarcoma, Wilms’ tumor and inflammatory bowel disease.
Lewis B. Silverman, MD, Director of the Leukemia Program
Silverman is a pediatric oncologist who specializes in the treatment of Acute Lymphoblastic Leukemia (ALL). He is director of the Jimmy Fund Clinic and the Pediatric Hematological Malignancy Service. His primary research focus is improving ALL therapies while reducing toxicity. In addition to his clinical and research responsibilities, he is also an assistant professor in Pediatrics at Harvard Medical School.
Christopher Weldon, MD, PhD
Weldon is a pediatric general surgeon with expertise in pediatric oncology and surgical critical care. His research focuses on chemotherapy resistance in solid tumors. He is also an instructor at Harvard Medical School.